 HOUSTON, Jan. 15, 2021 GLOBE NEWSWIRE -- Salarius Pharm aceuticals, Inc. Nasdaq: SLRX, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Daniela Y. Santiesteban, Ph.D., Director of Research and Business Development at Salarius Pharmaceuticals, has been invited to participate in a panel discussion during Noble Capital Markets 17th Annual Small Microcap Investor Conference NobleCon17. The conference is taking place January 19-21, 2021 over a virtual platform. 